
Edgewell Personal Care's fiscal fourth quarter net sales rose 3.0% to $484.1 million, with organic growth of 3.1%, while adjusted earnings per share rose 50.0% to $0.78 and GAAP earnings per share were $0.23.
Ticker: EPC
Edgewell Personal Care (EPC) reported fourth quarter and fiscal 2026 results on 12 November for the periods ended 30 September 2026. Results are for continuing operations and exclude the Feminine Care business, which is treated as discontinued. Gross margin rose 320 basis points to 43.3% of net sales, and adjusted gross margin rose 510 basis points to 45.7%.
The key numbers (quarter ended 30 September 2026)
Q4 FY2026 | Q4 FY2025 | Change | |
|---|---|---|---|
Net sales | $484.1 million | $469.9 million | +3.0% |
Gross profit | $209.6 million | $188.4 million | Up |
Operating income | $16.9 million | $6.9 million | Up |
Adjusted operating income | $51.1 million | $27.7 million | Up |
Net earnings, continuing operations | $10.7 million | $12.1 million | Down |
GAAP diluted EPS | $0.23 | $0.26 | Down |
Adjusted EPS | $0.78 | $0.52 | +50.0% |
Adjusted EBITDA | $76.8 million | $43.0 million | Up |
Advertising and sales promotion spending rose to $56.1 million, or 11.6% of net sales, from $45.9 million. The company recorded $29.9 million of pre-tax restructuring and related costs in the quarter.
Segments and regions
Wet Shave: net sales of $325.8 million, up 1.2%, or 1.6% on an organic basis. Segment profit rose 10.8% to $58.7 million.
Sun and Skin Care: net sales of $158.3 million, up 7.0%, or 6.5% on an organic basis, led by global Grooming. Segment profit rose to $19.7 million from $5.0 million.
North America organic sales rose 3.3% and International organic sales rose 3.0%.
Dividend and buybacks
The board declared a quarterly dividend of $0.15 per share, payable on 7 January 2027 to shareholders of record on 3 December 2026. Edgewell paid $6.9 million in dividends in the quarter and had about $85 million available for share repurchases as of 30 September 2026.
CEO Rod Little said fiscal 2026 "was a year of meaningful progress and change for Edgewell, culminating in a strong fourth quarter."
Full year
Fiscal 2026 net sales rose 1.8% to $1,996.5 million from $1,962.0 million, with organic growth of 0.3%. GAAP results showed a loss of $0.05 per share, against earnings of $0.93 a year earlier, after $101.8 million of restructuring and related costs. Adjusted EPS rose 6.6% to $1.93 from $1.81, and adjusted EBITDA was $254.5 million, against $239.7 million. Cash on hand was $375.6 million at year end.
Source: Edgewell Personal Care fourth quarter and fiscal 2026 earnings release dated 12 November 2026, SEC Form 8-K Exhibit 99.1: https://www.sec.gov/Archives/edgar/data/1096752/000162828026073042/q4fy26-epcexhibit991.htm
Comments
Log in or sign up to join the conversation.